Skip to main content
Log in

Antioxidant activity of topiramate: an antiepileptic agent

  • Original Article
  • Published:
Neurological Sciences Aims and scope Submit manuscript

Abstract

A number of experimental and clinical reports suggest the involvement of oxidative stress in pathophysiology of epilepsy. Topiramate, a new antiepileptic drug, induces antioxidant effect in epileptic animals. However, to date, no further studies appear to be carried out in order to demonstrate the ability of topiramate to act as antioxidant. Therefore, the objective of this work was to evaluate the in vitro superoxide (O ·−2 ), hydroxyl radical (OH·), hypochlorous acid (HOCl), hydrogen peroxide (H2O2), singlet oxygen (1O2) and peroxynitrite (ONOO) scavenging capacity of topiramate in comparison with reference compounds. In addition, we investigated the possible antitumour activity of this compound in some cancer cell lines. Topiramate displays a scavenging capacity compared to the reference compound, with the exception of ONOO, although it was less efficient than nordihydroguaiaretic acid, dimethylthiourea, ascorbic acid, sodium pyruvate and glutathione for O ·−2 , OH·, HOCl, H2O2 and 1O2 (P < 0.0001), respectively, and not induced significant growth inhibition in cancer cell lines. The direct antioxidant properties of topiramate could explain the neuroprotective effects attributed to this compound and suggest its use as chemopreventive agent in a future.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Ilhan A, Gurel A, Armutcu F, Kamisli S, Iraz M (2005) Antiepileptogenic and antioxidant effects of Nigella sativa oil against pentylenetetrazol-induced kindling in mice. Neuropharmacology 49:456–464

    Article  PubMed  CAS  Google Scholar 

  2. Whanger PD (2001) Selenium and the brain: a review. Nutr Neurosci 4:81–97

    PubMed  CAS  Google Scholar 

  3. Arrigoni O, De Tullio MC (2002) Ascorbic acid: much more than just an antioxidant. Biochim Biophys Acta 1569:1–9

    Article  PubMed  CAS  Google Scholar 

  4. Czernichow S, Hersberg S (2001) Interventional studies concerning the role of antioxidant vitamins in cardiovascular disease: a review. J Nutr Health Aging 5:188–195

    PubMed  CAS  Google Scholar 

  5. Nazıroğlu M, Karaoglu A, Aksoy AO (2004) Selenium and high dose vitamin E administration protects cisplatin-induced oxidative damage to renal, liver and lens tissues in rats. Toxicology 195:221–230

    Article  PubMed  Google Scholar 

  6. Özmen I, Naziroğlu M, Alici HA, Sahin F, Cengiz M, Eren I (2007) Spinal morphine administration reduces the fatty acid contents in spinal cord and brain in rabbits due to oxidative stress. Neurochem Res 32:19–25

    Article  PubMed  Google Scholar 

  7. Yatin SM, Varadarajan S, Butterfield DA (2000) Vitamin E prevents Alzheimer’s amyloid beta-peptide (1–42)-induced neuronal protein oxidation and reactive oxygen species production. J Alzheimers Dis 2:123–131

    PubMed  CAS  Google Scholar 

  8. Naziroğlu M, Uğuz AC, Gokçimen A, Bülbül M, Karatopuk DU, Türker Y, Cerçi C (2008) Tenoxicam modulates antioxidant redox system and lipid peroxidation in rat brain. Neurochem Res 33:1832–1837

    Article  PubMed  Google Scholar 

  9. Patel M (2004) Mitochondrial dysfunction and oxidative stress: cause and consequence of epileptic seizures. Free Radic Biol Med 37:1951–1962

    Article  PubMed  CAS  Google Scholar 

  10. Frantseva MV, Perez Velazquez JL, Tsoraklidis G, Mendonca AJ, Adamchik Y, Mills LR, Carlen PL, Burnham MW (2000) Oxidative stress is involved in seizure-induced neurodegeneration in the kindling model of epilepsy. Neuroscience 97:431–435

    Article  PubMed  CAS  Google Scholar 

  11. Armağan A, Kutluhan S, Yılmaz M, Yılmaz N, Bulbul M, Vural H, Soyupek S, Nazıroğlu M (2008) Topiramate and vitamin E modulates antioxidant enzymes, nitric oxide and lipid peroxidation in pentylenetetrazol-induced nephrotoxicity in rats. Basic Clin Pharm Toxicol 103:166–170

    Article  Google Scholar 

  12. Uma Devi P, Pillai KK, Vohora D (2006) Modulation of pentylenetetrazol-induced seizures and oxidative stress parameters by sodium valproate in the absence and presence of N-acetylcysteine. Fund Clin Pharmacol 20:247–253

    Article  CAS  Google Scholar 

  13. White HS, Smith MD, Wilcox KS (2007) Mechanisms of action of antiepileptic drugs. Int Rev Neurobiol 81:85–91

    Article  PubMed  CAS  Google Scholar 

  14. Perucca E (1997) A pharmacological and clinical review on topiramate, a new antiepileptic drug. Pharmacol Res 35:241–256

    Article  PubMed  CAS  Google Scholar 

  15. Rosenfeld WE (1997) Topiramate: a review of preclinical, pharmacokinetic, and clinical data. Clin Ther 19:1294–1308

    Article  PubMed  CAS  Google Scholar 

  16. Schneiderman JH (1998) Topiramate: pharmacokinetics and pharmacodynamics. Can J Neurol Sci 25:S3–S5

    PubMed  CAS  Google Scholar 

  17. Cardile V, Pavone A, Renis M, Maci T, Perciavalle V (2001) Effects of gabapentin and topiramate in primary rat astrocyte cultures. Neuro Report 12:1705–1708

    CAS  Google Scholar 

  18. Maldonado PD, Rivero-Cruz I, Mata R, Pedraza-Chaverri J (2005) Antioxidant activity of A-type proanthocyanidins from Geranium niveum (Geraniaceae). J Agric Food Chem 53:1996–2001

    Article  PubMed  CAS  Google Scholar 

  19. Medina-Campos ON, Barrera D, Segoviano-Murillo S, Rocha D, Maldonado PD, Mendoza-Patiño N, Pedraza-Chaverri J (2007) S-allylcysteine scavenges singlet oxygen and hypochlorous acid and protects LLC-PK(1) cells of potassium dichromate-induced toxicity. Food Chem Toxicol 45:2030–2039

    Article  PubMed  CAS  Google Scholar 

  20. Floriano-Sánchez E, Villanueva C, Medina-Campos ON, Rocha D, Sánchez-González DJ, Cárdenas-Rodríguez N, Pedraza-Chaverri J (2006) Nordihydroguaiaretic acid is a potent in vitro scavenger of peroxynitrite, singlet oxygen, hydroxyl radical, superoxide anion and hypochlorous acid and prevents in vivo ozone-induced tyrosine nitration in lungs. Free Radic Res 40:523–533

    Article  PubMed  Google Scholar 

  21. Skehan P, Storeng R, Scudiero D, Monks A, McMahon J, Vistica D, Warren JT, Bokesch H, Kenney S, Boyd MR (1990) New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst 82:1107–1112

    Article  PubMed  CAS  Google Scholar 

  22. Kubera M, Budziszewska B, Jaworska-Feil L, Basta-Kaim A, Leśkiewicz M, Tetich M, Maes M, Kenis G, Marciniak A, Czuczwar SJ, Jagła G, Nowak W, Lasoń W (2004) Effect of topiramate on the kainate-induced status epilepticus, lipid peroxidation and immunoreactivity of rats. Pol J Pharmacol 56:553–561

    PubMed  CAS  Google Scholar 

  23. Kutluhan S, Naziroğlu M, Celik O, Yilmaz M (2009) Effects of selenium and topiramate on lipid peroxidation and antioxidant vitamin levels in blood of pentylenetetrazol-induced epileptic rats. Biol Trace Elem Res 129:181–189

    Article  PubMed  CAS  Google Scholar 

  24. Muriach M, López-Pedrajas R, Barcia JM, Sanchez-Villarejo MV, Almansa I, Romero FJ (2010) Cocaine causes memory and learning impairments in rats: involvement of nuclear factor kappa B and oxidative stress, and prevention by topiramate. J Neurochem 114:675–684

    Article  PubMed  CAS  Google Scholar 

  25. Agarwal NB, Agarwal NK, Mediratta PK, Sharma KK (2011) Effect of lamotrigine, oxcarbazepine and topiramate on cognitive functions and oxidative stress in PTZ-kindled mice. Seizure 20:257–262

    Article  PubMed  Google Scholar 

  26. Pavone A, Cardile V (2003) An in vitro study of new antiepileptic drugs and astrocytes. Epilepsia 44:34–39

    Article  PubMed  CAS  Google Scholar 

  27. Christensen J, Hojskov CS, Dam M, Poulsen JH (2001) Plasma concentration of topiramate correlates with cerebrospinal fluid concentration. Ther Drug Monit 23:529–535

    Article  PubMed  CAS  Google Scholar 

  28. Recacha R, Costanzo MJ, Maryanoff BE, Chattopadhyay D (2002) Crystal structure of human carbonic anhydrase II complexed with an anti-convulsant sugar sulphamate. Biochem J 361:437–441

    Article  PubMed  CAS  Google Scholar 

  29. Casini A, Antel J, Abbate F, Scozzafava A, David S, Waldeck H, Schäfer S, Supuran CT (2003) Carbonic anhydrase inhibitors: SAR and X-ray crystallographic study for the interaction of sugar sulfamates/sulfamides with isozymes I, II and IV. Bioorg Med Chem Lett 13:841–845

    Article  PubMed  CAS  Google Scholar 

  30. Vullo D, Innocenti A, Nishimori I, Pastorek J, Scozzafava A, Pastoreková S, Supuran CT (2005) Carbonic anhydrases inhibitors. Inhibition of the transmembrane isozyme XII with sulfonamides—a new target for the design of antitumor and antiglaucoma drugs? Bioorg Med Chem Lett 15:963–969

    Article  PubMed  CAS  Google Scholar 

  31. Ma B, Pan Y, Song Q, Tie L, Zhang Y, Xiao Y, Zhang J, Han J, Xu Y, Xiang Y, Yu HM, Li XJ (2011) The effect of topiramate on tumor-related angiogenesis and on the serum proteome of mice bearing Lewis lung carcinoma. Eur J Pharmacol 663:9–16

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to N. Cárdenas-Rodríguez.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cárdenas-Rodríguez, N., Coballase-Urrutia, E., Huerta-Gertrudis, B. et al. Antioxidant activity of topiramate: an antiepileptic agent. Neurol Sci 34, 741–747 (2013). https://doi.org/10.1007/s10072-012-1127-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10072-012-1127-5

Keywords

Navigation